Both Resting and Activated B Lymphocytes Expressing Engineered Peptide-Ig Molecules Serve as Highly Efficient Tolerogenic Vehicles in Immunocompetent Adult Recipients

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)2174-2182
Number of pages9
JournalJournal of Immunology
Volume158
Issue number5
Publication statusPublished - Mar 1 1997
Externally publishedYes

    Fingerprint

Cite this